The FDA granted orphan drug designation to cintredekin besudotox for glioblastoma, supporting further research for this ...
FDA grants orphan drug designation to cintredekin besudotox, offering new hope for glioblastoma treatment with targeted ...
The global nanomedicine market size reached US$ 169.51 Billion in 2024 and is expected to reach US$ 389.52 Billion by 2033, ...
Cancer remains a leading cause of global morbidity and mortality. Traditional therapies like chemotherapy and radiotherapy are often limited by their ...
Monteris Medical, the leader in laser interstitial thermal therapy (LITT) for use in the brain, and Symphony Robotics, the pioneer in AI-powered micro-robotics, today announced a strategic partnership ...
News-Medical.Net on MSN
Multimodal nanocarriers offer targeted solutions for tumor treatment
Cancer remains a leading cause of global morbidity and mortality. Traditional therapies like chemotherapy and radiotherapy ...
Programmable proteins designed with Boolean logic gates may improve targeted drug delivery precision and scalability, ...
The human brain comprises billions of neurons, synapses, and cell types, making it one of the universe's most intricate and dynamic structures. However, the complexity and sensitivity of the brain can ...
Pharmaceutical Technology on MSN
Trogenix lands $95m Series A, backed by Eli Lilly, for brain cancer therapy
"Trogenix lands $95m Series A, backed by Eli Lilly, for brain cancer therapy" was originally created and published by ...
The human brain comprises billions of neurons, synapses, and cell types, making it one of the universe’s most intricate and dynamic structures. However, the complexity and sensitivity of the brain can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results